crenolanib
Showing 1 - 11 of 11
Acute Myeloid Leukemia Trial in Ulm (chemo (Mitoxantrone, Cytarabine), Placebo, Crenolanib)
Terminated
- Acute Myeloid Leukemia
- chemotherapy (Mitoxantrone, Cytarabine)
- +3 more
-
Ulm, GermanyUlm University Hospital
Sep 28, 2021
GIST With D842V Mutated PDGFRA Gene Trial in Worldwide (Crenolanib, Placebo)
Active, not recruiting
- GIST With D842V Mutated PDGFRA Gene
- Crenolanib
- Placebo
-
Santa Monica, California
- +22 more
Jan 21, 2021
Recurrent/Refractory Glioblastoma Trial in Houston (crenolanib)
Completed
- Recurrent/Refractory Glioblastoma
- crenolanib
-
Houston, TexasMD Anderson Cancer Center
Jul 17, 2020
Esophagogastric Adenocarcinoma Trial in New York (Crenolanib, Ramucirumab, Paclitaxel)
Completed
- Esophagogastric Adenocarcinoma
- Crenolanib
- +2 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jul 17, 2020
Relapsed/Refractory Acute Myeloid Leukemia With FLT3 Activating Mutations Trial in Worldwide (Crenolanib, Cytarabine,
Recruiting
- Relapsed/Refractory Acute Myeloid Leukemia With FLT3 Activating Mutations
- Crenolanib
- +6 more
-
Sacramento, California
- +61 more
Apr 28, 2021
Newly Diagnosed AML With FLT3 Activating Mutations Trial in United States (crenolanib, cytarabine, daunorubicin)
Completed
- Newly Diagnosed AML With FLT3 Activating Mutations
- crenolanib
- +3 more
-
Duarte, California
- +8 more
Jul 17, 2020
Newly Diagnosed FLT3 Mutated AML Trial in United States (Crenolanib, Midostaurin, Cytarabine)
Recruiting
- Newly Diagnosed FLT3 Mutated AML
- Crenolanib
- +3 more
-
Duarte, California
- +30 more
May 21, 2020
Relapsed/Refractory Acute Myeloid Leukemia (AML) Trial in United States (Crenolanib, Mitoxantrone, Cytarabine)
Completed
- Relapsed/Refractory Acute Myeloid Leukemia (AML)
- Crenolanib
- +6 more
-
Little Rock, Arkansas
- +3 more
May 8, 2019
Relapsed/Refractory FLT3-mutated AML Trial (Crenolanib, Fludarabine, Cytarabine)
Withdrawn
- Relapsed/Refractory FLT3-mutated AML
- Crenolanib
- +2 more
- (no location specified)
Jan 8, 2019
Acute Myeloid Leukemia Trial in Memphis (Crenolanib, Sorafenib, methotrexate, hydrocortisone and cytarabine with leucovorin)
Completed
- Acute Myeloid Leukemia
- Crenolanib
- +2 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Oct 2, 2017
Diffuse Intrinsic Pontine Glioma, Progressive or Refractory High-Grade Glioma Trial in Memphis (Crenolanib)
Completed
- Diffuse Intrinsic Pontine Glioma
- Progressive or Refractory High-Grade Glioma
- Crenolanib
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Apr 24, 2017